Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Sarah Cannon Research Institute
What AI says about Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) specializes in oncology research and conducts community-based clinical trials. With over 30 years of experience, SCRI has significantly contributed to the development of new cancer therapies approved by the FDA.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
Products & Services
Clinical Trial Site Management
End-to-end management of clinical trial sites, including operational and regulatory support for industry-sponsored and investigator-initiated trials.
Contract Research Organization (CRO)
SCRI Development Innovations provides full-service contract research organization services specializing in oncology clinical development from first-in-human studies to regulatory approval.
Personalized Medicine Program
Transforms real-world data into actionable insights to match the right therapy to the right patient at the right time.
Common Questions
What types of clinical trials does SCRI conduct?
SCRI conducts community-based clinical trials focused on oncology, including both solid tumor and hematologic malignancies.
How many locations does SCRI operate in?
SCRI operates in over 200 locations across 20 states in the U.S.
What is the goal of SCRI's Personalized Medicine Program?
The goal is to match the right therapy to the right patient at the right time using actionable insights from real-world data.
How many clinical trials has SCRI conducted?
SCRI has conducted more than 850 first-in-human clinical trials since its inception.
Who can participate in SCRI's clinical trials?
Patients with cancer can participate, as SCRI's network reaches 1 in 5 patients with cancer in the U.S.